Description:
Azilsartan Medoxomil is a potent angiotensin II type 1 (AT1) receptor antagonist that inhibits the RAAS, with an IC50 of 2.6 nM. It exhibits more than 10,000-fold selectivity over AT2. Azilsartan Medoxomil can be used for the treatment of mild to moderate essential hypertension.
- Molecular Weight: 568.53
- Molecular Formula: C30H24N4O8
Purity: >98%
Canonical SMILES:
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)OCC6=C(OC(=O)O6)C
InChI:
InChI=1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36)
InChIKey: QJFSABGVXDWMIW-UHFFFAOYSA-N
- Boiling Point: 748.0±70.0 °C at 760 mmHg
- Melting Point: 212-214 °C
- Solubility: Water: practically insoluble
- Appearance: -
- Application: the treatment of mild to moderate essential hypertension
Synonyms:
TAK-491 Medoxomil; TAK491 Medoxomil; Edarbi; 863031-21-4; Azilsartan (medoxomil); TAK 491; UNII-LL0G25K7I2
More details are to be found on supplier website